These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 30760354)
1. Irreversible Electroporation as a Bridge to Liver Transplantation. Cannon RM; Bolus DN; White JA Am Surg; 2019 Jan; 85(1):103-110. PubMed ID: 30760354 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of tolerability and efficacy of irreversible electroporation (IRE) in treatment of Child-Pugh B (7/8) hepatocellular carcinoma (HCC). Bhutiani N; Philips P; Scoggins CR; McMasters KM; Potts MH; Martin RC HPB (Oxford); 2016 Jul; 18(7):593-9. PubMed ID: 27346140 [TBL] [Abstract][Full Text] [Related]
5. Irreversible Electroporation of Malignant Hepatic Tumors--Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up. Dollinger M; Müller-Wille R; Zeman F; Haimerl M; Niessen C; Beyer LP; Lang SA; Teufel A; Stroszczynski C; Wiggermann P PLoS One; 2015; 10(8):e0135773. PubMed ID: 26270651 [TBL] [Abstract][Full Text] [Related]
6. Single-center nonrandomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term results. Frühling P; Nilsson A; Duraj F; Haglund U; Norén A Eur J Surg Oncol; 2017 Apr; 43(4):751-757. PubMed ID: 28109674 [TBL] [Abstract][Full Text] [Related]
7. Ablation of perivascular hepatic malignant tumors with irreversible electroporation. Kingham TP; Karkar AM; D'Angelica MI; Allen PJ; Dematteo RP; Getrajdman GI; Sofocleous CT; Solomon SB; Jarnagin WR; Fong Y J Am Coll Surg; 2012 Sep; 215(3):379-87. PubMed ID: 22704820 [TBL] [Abstract][Full Text] [Related]
8. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area. Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332 [TBL] [Abstract][Full Text] [Related]
9. Midterm Safety and Efficacy of Irreversible Electroporation of Malignant Liver Tumors Located Close to Major Portal or Hepatic Veins. Distelmaier M; Barabasch A; Heil P; Kraemer NA; Isfort P; Keil S; Kuhl CK; Bruners P Radiology; 2017 Dec; 285(3):1023-1031. PubMed ID: 28799842 [TBL] [Abstract][Full Text] [Related]
10. Allogenic Natural Killer Cell Immunotherapy Combined with Irreversible Electroporation for Stage IV Hepatocellular Carcinoma: Survival Outcome. Alnaggar M; Lin M; Mesmar A; Liang S; Qaid A; Xu K; Chen J; Niu L; Yin Z Cell Physiol Biochem; 2018; 48(5):1882-1893. PubMed ID: 30092590 [TBL] [Abstract][Full Text] [Related]
11. Irreversible Electroporation of Recurrent Hepatocellular Carcinoma After Liver Transplantation: Report of Two Cases. Akhan O; Sarıkaya Y; Köksal A; Ünal E; Çiftçi T; Akıncı D Cardiovasc Intervent Radiol; 2021 May; 44(5):807-811. PubMed ID: 33655357 [TBL] [Abstract][Full Text] [Related]
12. Similar complication rates for irreversible electroporation and thermal ablation in patients with hepatocellular tumors. Verloh N; Jensch I; Lürken L; Haimerl M; Dollinger M; Renner P; Wiggermann P; Werner JM; Zeman F; Stroszczynski C; Beyer LP Radiol Oncol; 2019 Mar; 53(1):116-122. PubMed ID: 30840591 [TBL] [Abstract][Full Text] [Related]
13. Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures. Cannon R; Ellis S; Hayes D; Narayanan G; Martin RC J Surg Oncol; 2013 Apr; 107(5):544-9. PubMed ID: 23090720 [TBL] [Abstract][Full Text] [Related]